These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 25585274)

  • 1. Bloodstream infections in adult patients undergoing cord blood transplantation from unrelated donors after myeloablative conditioning regimen.
    Sanz J; Cano I; González-Barberá EM; Arango M; Reyes J; Montesinos P; Lorenzo I; Jarque I; Martínez J; López F; Arilla MJ; Lancharro A; Moscardó F; López-Hontangas JL; Salavert M; Sanz MA; Sanz GF
    Biol Blood Marrow Transplant; 2015 Apr; 21(4):755-60. PubMed ID: 25585274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-engraftment bloodstream infections in acute leukemia patients undergoing unrelated cord blood transplantation following intensified myeloablative conditioning without ATG.
    Zheng C; Tang B; Zhu X; Zhang X; Zhang L; Geng L; Liu H; Sun Z
    Ann Hematol; 2017 Jan; 96(1):115-124. PubMed ID: 27771742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence, risk factors and outcomes of early bloodstream infection in patients with malignant hematologic disease after unrelated cord blood transplantation: a retrospective study.
    Ge J; Yang T; Zhang L; Zhang X; Zhu X; Tang B; Wan X; Tong J; Song K; Yao W; Sun G; Sun Z; Liu H
    BMC Infect Dis; 2018 Dec; 18(1):654. PubMed ID: 30545330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
    Blennow O; Ljungman P; Sparrelid E; Mattsson J; Remberger M
    Transpl Infect Dis; 2014 Feb; 16(1):106-14. PubMed ID: 24372809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen.
    Sanz J; Boluda JC; Martín C; González M; Ferrá C; Serrano D; de Heredia CD; Barrenetxea C; Martinez AM; Solano C; Sanz MA; Sanz GF;
    Bone Marrow Transplant; 2012 Oct; 47(10):1287-93. PubMed ID: 22327127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for pre- and post-engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation.
    Kikuchi M; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Sakamoto K; Kawamura K; Ishihara Y; Sato M; Ashizawa M; Terasako-Saito K; Kimura S; Yamazaki R; Kanda J; Kako S; Nishida J; Kanda Y
    Transpl Infect Dis; 2015 Feb; 17(1):56-65. PubMed ID: 25580541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased nonrelapse mortality after unrelated cord blood transplantation for acute myeloid leukemia using reduced-intensity conditioning: a prospective phase II multicenter trial.
    Rio B; Chevret S; Vigouroux S; Chevallier P; Fürst S; Sirvent A; Bay JO; Socié G; Ceballos P; Huynh A; Cornillon J; Françoise S; Legrand F; Yakoub-Agha I; Michel G; Maillard N; Margueritte G; Maury S; Uzunov M; Bulabois CE; Michallet M; Clement L; Dauriac C; Bilger K; Gluckman E; Ruggeri A; Buzyn A; Nguyen S; Simon T; Milpied N; Rocha V;
    Biol Blood Marrow Transplant; 2015 Mar; 21(3):445-53. PubMed ID: 25460357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete donor T cell chimerism predicts lower relapse incidence after standard double umbilical cord blood reduced-intensity conditioning regimen allogeneic transplantation in adults.
    Peterlin P; Delaunay J; Guillaume T; Gastinne T; Mahé B; Dubruille V; Blin N; Le Bourgeois A; Brissot E; Lodé L; Le Gouill S; Moreau P; Mohty M; Chevallier P
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):180-4. PubMed ID: 25175796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and risk factors of early bacterial infections after unrelated cord blood transplantation.
    Yazaki M; Atsuta Y; Kato K; Kato S; Taniguchi S; Takahashi S; Ogawa H; Kouzai Y; Kobayashi T; Inoue M; Kobayashi R; Nagamura-Inoue T; Azuma H; Takanashi M; Kai S; Nakabayashi M; Saito H;
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):439-46. PubMed ID: 19285631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial bloodstream infection in neutropenic adult patients after myeloablative cord blood transplantation: experience of a single institution in Japan.
    Tomonari A; Takahashi S; Ooi J; Tsukada N; Konuma T; Kobayashi T; Sato A; Takasugi K; Iseki T; Tojo A; Asano S
    Int J Hematol; 2007 Apr; 85(3):238-41. PubMed ID: 17483061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-engraftment syndrome after unrelated donor umbilical cord blood transplantation in patients with hematologic malignancies.
    Wang X; Liu H; Li L; Geng L; Ding K; Liu X; Tong J; Zhu W; Sun Z
    Eur J Haematol; 2012 Jan; 88(1):39-45. PubMed ID: 21933279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infectious complications after unrelated umbilical cord blood transplantation in adult patients with hematologic malignancies.
    Cahu X; Rialland F; Touzeau C; Chevallier P; Guillaume T; Delaunay J; Ayari S; Dubruille V; Le Gouill S; Mahe B; Gastinne T; Blin N; Saulquin B; Harousseau JL; Moreau P; Mohty M
    Biol Blood Marrow Transplant; 2009 Dec; 15(12):1531-7. PubMed ID: 19896076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early infections in adult patients undergoing unrelated donor cord blood transplantation.
    Saavedra S; Sanz GF; Jarque I; Moscardó F; Jiménez C; Lorenzo I; Martín G; Martínez J; De La Rubia J; Andreu R; Mollá S; Llopis I; Fernández MJ; Salavert M; Acosta B; Gobernado M; Sanz MA
    Bone Marrow Transplant; 2002 Dec; 30(12):937-43. PubMed ID: 12476288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-Engraftment Bloodstream Infections after Allogeneic Hematopoietic Cell Transplantation: Impact of T Cell-Replete Transplantation from a Haploidentical Donor.
    Mikulska M; Raiola AM; Galaverna F; Balletto E; Borghesi ML; Varaldo R; Gualandi F; Giannoni L; Pastori G; Giacobbe DR; Signori A; Del Bono V; Viscoli C; Bacigalupo A; Angelucci E
    Biol Blood Marrow Transplant; 2018 Jan; 24(1):109-118. PubMed ID: 28860000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of outcomes after two standards-of-care reduced-intensity conditioning regimens and two different graft sources for allogeneic stem cell transplantation in adults with hematologic diseases: a single-center analysis.
    Le Bourgeois A; Mohr C; Guillaume T; Delaunay J; Malard F; Loirat M; Peterlin P; Blin N; Dubruille V; Mahe B; Gastinne T; Le Gouill S; Moreau P; Mohty M; Planche L; Lode L; Bene MC; Chevallier P
    Biol Blood Marrow Transplant; 2013 Jun; 19(6):934-9. PubMed ID: 23523970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unrelated cord blood transplantation: outcomes after single-unit intrabone injection compared with double-unit intravenous injection in patients with hematological malignancies.
    Rocha V; Labopin M; Ruggeri A; Podestà M; Gallamini A; Bonifazi F; Sanchez-Guijo FM; Rovira M; Socie G; Baltadakis I; Michallet M; Deconinck E; Bacigalupo A; Mohty M; Gluckman E; Frassoni F
    Transplantation; 2013 May; 95(10):1284-91. PubMed ID: 23507699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of bloodstream infections after myeloablative and non-myeloablative allogeneic hematopoietic stem cell transplantation: A single-center cohort study.
    Gjaerde LI; Moser C; Sengeløv H
    Transpl Infect Dis; 2017 Oct; 19(5):. PubMed ID: 28561378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative outcomes between cord blood transplantation and bone marrow or peripheral blood stem cell transplantation from unrelated donors in patients with hematologic malignancies: a single-institute analysis.
    Chen YH; Xu LP; Liu DH; Chen H; Zhang XH; Han W; Wang FR; Wang JZ; Wang Y; Huang XJ; Liu KY
    Chin Med J (Engl); 2013 Jul; 126(13):2499-503. PubMed ID: 23823825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Six-month incidence of bloodstream infections in intestinal transplant patients.
    Akhter K; Timpone J; Matsumoto C; Fishbein T; Kaufman S; Kumar P
    Transpl Infect Dis; 2012 Jun; 14(3):242-7. PubMed ID: 22093913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Features of EBV reactivation after reduced intensity conditioning unrelated umbilical cord blood transplantation.
    Peric Z; Cahu X; Chevallier P; Brissot E; Malard F; Guillaume T; Delaunay J; Ayari S; Dubruille V; Le Gouill S; Mahé B; Gastinne T; Blin N; Saulquin B; Harousseau JL; Moreau P; Coste-Burel M; Imbert-Marcille BM; Mohty M
    Bone Marrow Transplant; 2012 Feb; 47(2):251-7. PubMed ID: 21441959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.